Biology Reference
In-Depth Information
41. Ransohoff RM, Perry VH. Microglial physiology: unique stimuli, specialised responses.
Annu Rev Immunol 2009;27:119-45.
42. Semple BD, Bye N, Rancan M, Ziebell JM, Morganti-Kossmann MC. CCL2 in neuro-
inflammation following traumatic brain injury (TBI): evidence from severe TBI patients
and CCL2-/- mice. J Cereb Blood Flow Metab, advanced online publication, 23 December
2009; doi:10.1038/jcbfm.2009.262.
43. Foda MA, Marmarou A. A new model of diffuse brain injury in rats. Part II: Morphologi-
cal characterization. J Neurosurg 1994;80(2):301-13.
44. Farkas O, Povlishock JT. Cellular and subcellular change evoked by diffuse traumatic
brain injury: a complex web of change extending far beyond focal damage. Prog Brain
Res 2007;161:43-59.
45. Csuka E, Hans VH, Ammann E, Trentz O, Kossmann T, Morganti-Kossmann MC.
Cell activation and inflammatory response following traumatic axonal injury in the rat.
Neuroreport 2000;11(11):2587-90.
46. Hellewell SC, Yan EB, Agyapomaa D, Morganti-Kossman MC. Post-traumatic hypoxia
worsens neuropathological damage in an animal model of diffuse axonal injury. Injury
2009;40(Suppl. 1):S20.
47. Andersson PB, Perry VH, Gordon S. The acute inflammatory response to lipopolysac-
charide in CNS parenchyma differs from that in other body tissues. Neuroscience
1992;48(1):169-86.
48. Banks WA. Blood-brain barrier transport of cytokines: a mechanism for neuropathology.
Curr Pharm Des 2005;11:973-84.
49. Kossmann T, Hans VH, Imhof HG, Stocker R, Grob P, Trentz O, et al. Intrathecal, and
serum interleukin-6 and the acute-phase response in patients with severe traumatic brain
injuries. Shock 1995;4(5):311-17.
50. Morganti-Kossmann M, Satgunaseelan L, Bye N, Kossmann T. Modulation of immune
response by head injury. Injury 2007;38(12):1392-400.
51. Lucas S-M, Rothwell NJ, Gibson RM. The role of inflammation in CNS injury and dis-
ease. Br J Pharmacol 2006;147:S232-40.
52. Correale J, Villa A. The neuroprotective role of inflammation in nervous system injuries.
J Neurol 2004;251:1304-16.
53. Kossmann T, Hans V, Imhof HG, Trentz O, Morganti-Kossmann MC. Interleukin-6
released in human cerebrospinal fluid following traumatic brain injury may trigger nerve
growth factor production in astrocytes. Brain Res 1996;713(1-2):143-52.
54. Kossmann T, Stahel PF, Lenzlinger PM, Redl H, Dubs RW, Trentz O, et al. Interleukin-8
released into the cerebrospinal fluid after brain injury is associated with blood-brain barrier dys-
function and nerve growth factor production. J Cereb Blood Flow Metab 1997;17(3):280-89.
55. Csuka E, Morganti-Kossmann MC, Lenzlinger PM, Joller H, Trentz O, Kossmann T.
IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain
injury: relationship to IL-6, TNF-alpha, TGF-beta1 and blood-brain barrier function.
J Neuroimmunol 1999;101(2):211-21.
56. Morganti-Kossmann MC, Hans VH, Lenzlinger PM, Dubs R, Ludwig E, Trentz O, et al.
TGF-beta is elevated in the CSF of patients with severe traumatic brain injuries and paral-
lels blood-brain barrier function. J Neurotrauma 1999;16(7):617-28.
57. Hans VH, Kossmann T, Lenzlinger PM, Probstmeier R, Imhof HG, Trentz O, et al.
Experimental axonal injury triggers interleukin-6 mRNA, protein synthesis and release
into cerebrospinal fluid. J Cereb Blood Flow Metab 1999;19(2):184-94.
58. Pleines UE, Morganti-Kossmann MC, Rancan M, Joller H, Trentz O, Kossmann T.
S-100 beta reflects the extent of injury and outcome, whereas neuronal specific enolase
